The needle-free injectors market study by Future Market insights (FMI) is intended to offer exclusive insights for various companies, helping them identify growth opportunities and navigate
/PRNewswire/ ESOMAR-certified market research firm Future Market Insights (FMI) has forecast the Needle-Free Injectors Market to exhibit a year-on-year.
Vaccine delivery devices market: Key Findings
North America owns the largest share in vaccine delivery device market. The market growth is supported by robust and advance medical infrastructure and growing awareness regarding vaccination.
Huge investment in research and development of new vaccine devices fuels the market growth in Europe.
Asia-Pacific region is forecast to observe tremendous growth owing to rising population and low vaccination rates along with rapid infrastructure development.
Intramuscular vaccine is gaining popularity among patients and is estimated to reach the valuation of US$ 1000 Mn by the end of 2022.
Syringes will also register healthy growth in global vaccine delivery device market owing to high utility during mass vaccination and inexpensive nature.
Share this article
Share this article
ResearchAndMarkets.com s offering.
This report titled needle free diabetes management market studies various device types such as treatment devices, diagnostic devices and artificial pancreas that respectively sub-segmented. According to the International Diabetes Federation, in 2015 one in 11 adult has diabetes and by 2040 it is expected that one in 10 adults will have diabetes. The data suggests that in 2015 every 6 seconds one person dies from diabetes. Thus, diabetes management is one of the most crucial parts to prevent life threatening effects of this disease. The ongoing research and development activities in field of diagnosis and treatment of diabetes are expected to change the aspect of market in coming years.